Applied Therapeutics, Inc.

Applied Therapeutics, Inc.verified

APLT

Price:

$0.2299

Market Cap:

$33.09M

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products in...[Read more]

Industry

Biotechnology

IPO Date

2019-05-14

Stock Exchange

NASDAQ

Ticker

APLT

The Enterprise Value as of December 2025 (TTM) for Applied Therapeutics, Inc. (APLT) is 23.64M

According to Applied Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 23.64M. This represents a change of -41.45% compared to the average of 40.38M of the last 4 quarters.

Applied Therapeutics, Inc. (APLT) Historical Enterprise Value (quarterly & annually)

How has APLT Enterprise Value performed in the past?

The mean historical Enterprise Value of Applied Therapeutics, Inc. over the last ten years is 172.46M. The current 23.64M Enterprise Value has changed 1.27% with respect to the historical average. Over the past ten years (40 quarters), APLT's Enterprise Value was at its highest in in the September 2024 quarter at 1.13B. The Enterprise Value was at its lowest in in the June 2022 quarter at -29103471.80.

Quarterly (TTM)
Annual

Average

172.46M

Median

130.10M

Minimum

14.07M

Maximum

428.82M

Applied Therapeutics, Inc. (APLT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Applied Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.56%

Maximum Annual Enterprise Value = 428.82M

Minimum Annual Increase = -92.07%

Minimum Annual Enterprise Value = 14.07M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202442.87M-81.61%
2023233.10M1.56%
202214.07M-92.07%
2021177.34M-58.65%
2020428.82M28.69%
2019333.22M394.51%
201867.38M-18.67%

Applied Therapeutics, Inc. (APLT) Average Enterprise Value

How has APLT Enterprise Value performed in the past?

The current Enterprise Value of Applied Therapeutics, Inc. (APLT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

96.68M

5-year avg

179.24M

10-year avg

172.46M

Applied Therapeutics, Inc. (APLT) Enterprise Value vs. Peers

How is APLT’s Enterprise Value compared to its peers?

Applied Therapeutics, Inc.’s Enterprise Value is less than Molecular Partners AG (45.15M), less than Elicio Therapeutics, Inc. (128.40M), less than Corbus Pharmaceuticals Holdings, Inc. (116.42M), less than Cardiff Oncology, Inc. (136.29M), less than PepGen Inc. (347.79M), less than Milestone Pharmaceuticals Inc. (235.37M), less than Rani Therapeutics Holdings, Inc. (123.77M), less than Nkarta, Inc. (155.82M), less than Cassava Sciences, Inc. (48.00M), less than Forte Biosciences, Inc. (164.14M),

Build a custom stock screener for Applied Therapeutics, Inc. (APLT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Applied Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Applied Therapeutics, Inc. (APLT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Applied Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Applied Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Applied Therapeutics, Inc. (APLT)?

What is the 3-year average Enterprise Value for Applied Therapeutics, Inc. (APLT)?

What is the 5-year average Enterprise Value for Applied Therapeutics, Inc. (APLT)?

How does the current Enterprise Value for Applied Therapeutics, Inc. (APLT) compare to its historical average?